News and Announcements
Cure Brain Cancer Foundation – CEO Interview
- Published October 29, 2014 12:20PM UTC
- Publisher Wholesale Investor
- Categories Executive Interviews
Cure Brain Cancer Foundation is the largest dedicated funder of brain cancer research in Australia. Partnering with the research community, we are steering the national agenda for brain cancer research. Our mission is to accelerate new treatments to brain cancer patients and increase five-year survival to 50% within 10 years. Our priorities are to:
- Bring together global brain cancer stakeholders to set and agree priorities and gain consensus for the Australian research component globally and locally.
- Identify and short-list research projects on the basis of their compatibility with the CBCF research strategy.
To find out more about Cure Brain Cancer Foundation please listen to CEO, Ms Catherine Stace.
Executive Interviews
Following the Billions: Where the Hyperscalers are Betting on the Future
The roadmap for the next decade isn’t hidden in pitch decks—it’s written on the balance sheets of Microsoft, Amazon, and Google. Their collective investment is flowing into three key areas: GPU Chips, AI Factories, and Energy. This foundational buildout signals a $7–$20 trillion economic convergence, where the physical race for infrastructure and energy is paramount. The article also covers the powerful macro case for digital assets in this new era.
The Great Re-Allocation: Why AI is Forcing Smart Money From Software to Hard Science
Smart money is rapidly shifting its investment focus from commoditized software to hard science and deep tech, as AI dissolves traditional software moats. Discover the dual pressure on investors and the pivot to businesses with durable, real-world defensive barriers.
AI is The Cheapest, Highest-Leverage Investment You Will Ever Make
AI tools offer a 10x productivity increase for a minimal monthly cost, making them the highest-ROI investment in business today. However, this massive potential remains dormant. The real opportunity is not in owning the tools, but in having the strategic playbook to deploy them organization-wide and build a defensible competitive advantage.
Backed By Leading Investment Groups and Family Offices
